Canada Consumer Product Safety Act (CCPSA) - PowerPoint PPT Presentation

1 / 27
About This Presentation
Title:

Canada Consumer Product Safety Act (CCPSA)

Description:

Title: Slide 1 Author: Dgirouar Last modified by: Ben Baker Created Date: 4/15/2010 3:43:43 PM Document presentation format: On-screen Show Company – PowerPoint PPT presentation

Number of Views:122
Avg rating:3.0/5.0
Slides: 28
Provided by: Dgir8
Category:

less

Transcript and Presenter's Notes

Title: Canada Consumer Product Safety Act (CCPSA)


1
Canada Consumer Product Safety Act(CCPSA)
2
Overview
  • Key Partners
  • From existing Hazardous Products Act to the
    Canada Consumer Product Safety Act.
  • Key New Industry Obligations
  • Section 14 Duties in the Event of an Incident
    (MR)
  • Preparing and Maintaining Documents
  • Recalls and other measures
  • Confidential Business Information Personal
    Information
  • Administrative Monetary Penalties (AMPs)
  • Implementation, Outreach Engagement

2
3
Canada Consumer Product Safety Act (CCPSA)
  • Came into force on June 20, 2011
  • Purpose (s.3) to protect the public by
    addressing or preventing dangers to human health
    or safety that are posed by consumer products in
    Canada
  • Consumer Product (s.2) a product, including
    its components, parts or accessories, that may
    reasonably be expected to be obtained by an
    individual to be used for non-commercial
    purposes, and includes its packaging.
  • Danger to Human Health or Safety (s.2) any
    unreasonable hazard existing or potential
    that is posed by a consumer product during or as
    a result of its normal or foreseeable use and
    that may reasonably be expected to cause death
    or adverse health effect.

3
4
Key Partners in Consumer Product Safety
  • Government New authorities and tools to
    promote and enforce compliance and take
    action where necessary.
  • Industry New responsibilities and
    obligations.
  • Consumers Better informed.
  • Overall Results
  • Safer consumer products.
  • Greater consumer confidence in products on the
    market.
  • Better protection of consumer health and safety.
  • More level playing field for responsible Canadian
    businesses and greater clarity of industrys
    obligations.
  • More consistency and compatibility with
    international trading partners and competitors.

4
4
5
Hazardous Products Act (HPA)
  • The HPA was introduced in an earlier era. It
    prohibits and restricts the advertising, sale and
    importation of hazardous products.
  • The HPA is reactive and focuses only on consumer
    products that have been regulated or prohibited.
  • Authority to require corrective action is
    limited.
  • Needed to renew our legislation close gaps with
    other jurisdictions, address unregulated
    products, early detection of issues, require
    corrective action.

5
6
CCPSA New Authorities and Requirements
  • Ability to order recall and other corrective
    measures.
  • Record-keeping to allow traceability in the event
    of a recall.
  • Mandatory reporting by industry of incidents
    related to their products (including near
    misses).
  • Ability to require tests and studies to verify
    compliance or prevent non-compliance.
  • Sharing/disclosure of information.
  • Increased fines and penalties including an
    administrative monetary penalties scheme (AMPs).
  • New General Prohibition.

6
7
Transfer of Regulations
7
8
Consumer Product Safety Net
  • The new authorities in the CCPSA will contribute
    to an improved and more comprehensive safety net
    through early warnings, surveillance, risk
    assessment and risk management.
  • These authorities should be seen as a more
    comprehensive approach in the context of a
    post-market regime.
  • Does not apply to certain products that are
    addressed by other legislation, such as
    explosives, cosmetics, drugs, food, medical
    devices, ammunition, and natural health products.

8
9
Key Industry Responsibilities
  • Mandatory reporting of health or safety related
    incidents with consumer products.
  • Mandatory record keeping for traceability of
    products throughout the supply chain.
  • Health Canada may request tests, studies and
    other information necessary to verify compliance
    or prevent non-compliance.
  • New general prohibition.
  • Compliance with regulations, prohibitions.

9
10
Mandatory Reporting
  • Mandatory Reporting is the requirement for
    Industry to report any incident related to a
    consumer product they supply as outlined in
    Section 14 of the CCPSA Duties in the Event of
    an Incident.
  • Intent of Section 14
  • Provide better intelligence on the use of
    consumer products and the potential risks with
    respect to human health and safety, enabling
    early and proactive response to emerging hazards
    / trends and
  • respond where appropriate to consumer product
    health and safety incidents.
  • The requirements for mandatory reporting are
    framed by 3 primary questions
  • 1. What is a reportable incident?
  • 2. When do I need to report the incident?
  • 3. How do I report the incident?

10
10
11
What is a Reportable Incident?
  • Upon learning of an event that may involve a
    companys product, it is expected that the
    company undertakes an evaluation to determine if
    it meets the requirement to be reported to Health
    Canada and if the product involved is a consumer
    product as defined in the legislation.
  • This determination is undertaken prior to
    timelines commencing for the mandatory incident
    reports.
  • The following questions can assist in the
    determination of a reportable incident
  • Does the event relate to a consumer product that
    I sell, manufacture or import in Canada for
    commercial purposes (including its components,
    parts or accessories or packaging)?
  • Does it meet the criteria of an incident in
    either one of paragraphs 14(1) (a) through (d)?
  • Does it indicate an unreasonable hazard posed by
    the normal or foreseeable use of the product or
    the foreseeable misuse of the product?

11
12
Determining Related Is my product connected
or involved?
  • When evaluating an event, the CCPSA requires a
    person to determine if the product involved
    (including its components, parts or accessories
    and its packaging) is related to a consumer
    product that they manufacture, import or sell in
    Canada for commercial purposes.
  • The event need not involve a consumer product
    that is exactly identical to the product the
    person manufactures, imports or sells in Canada.
    This may be the case, for instance, if the
    consumer product the person supplies shares a
    component, accessory or part with the product
    involved in the incident.
  • An additional consideration for the aspect of
    "relate" requires a person to determine if the
    consumer product is connected with the event.

12
13
Meeting CCPSA Section 14 (1)(a-d) Criteria
  • 14 (1)(a) An occurrence in Canada or elsewhere
    that resulted or may reasonably have been
    expected to result in an individuals death or in
    serious adverse effects on their health,
    including a serious injury
  • 14 (1)(b) A defect or characteristic that may
    reasonably be expected to result in an
    individuals death or in serious adverse effects
    on their health, including a serious injury
  • 14 (1)(c) Incorrect or insufficient information
    on a label or package - or the lack of a label or
    instructions that may reasonably be expected to
    result in an individuals death or in serious
    adverse effects on their health, including a
    serious injury or
  • 14 (1)(d) Recall or other measure that was
    initiated for human health or safety reasons by
    another jurisdiction (including foreign entity)
    (refer to subparagraphs 14(1)(d)(i) to (v)).

13
14
Normal / Foreseeable Use or Misuse
  • For an event to be an incident, particularly for
    paragraphs 14 (a) to (c), it should be determined
    that the event indicates an unreasonable hazard
    posed by the normal or foreseeable use or misuse
    of the product.
  • Experience and judgment need to guide whether the
    consumer product was being used as it was
    originally intended to be used but must also
    extend to foreseeable but unintended use of the
    product.
  • Foreseeable use would include not only the use of
    a consumer product for its primary, ordinary or
    intended purpose, but also the misuse of a
    product that is reasonably foreseeable. What
    constitutes normal or foreseeable use of a
    consumer product will depend on the particular
    product involved, and with the circumstances
    surrounding the event.

14
15
15
16
When Who to Report to
16
16
17
How to Report
17
18
Document Retention Requirements
RETAILER ALL OTHER PERSONS (Manufacture, import, advertise, sell or test products for commercial purposes)
Shall prepare and maintain documents that indicate the name and address of the person from whom they obtained the product and the location where and the period during which they sold the product. Shall prepare and maintain the prescribed documents. Shall prepare and maintain documents that indicate the name and address of the person from whom they obtained the product or to whom they sold it, or both, as applicable. Shall prepare and maintain the prescribed documents.
18
19
Document Retention Requirements
  • Period for Document Retention
  • Persons are required to keep documents until the
    expiry of six years after the end of the year to
    which they relate, unless regulations specify
    another time period.
  • Keeping Documents in Canada
  • Documents must be kept at your place of business
    in Canada or at any place prescribed by
    regulation the expectation is to facilitate
    access.
  • The Minister may grant an exemption if he or she
    considers that keeping the documents in Canada is
    unnecessary or impractical.
  • Providing Documents
  • Inspectors may request access to documents that
    are required to be maintained under section 13
    and its regulations.
  • Health Canada may also make a written request for
    documents under section 12. The request will set
    out the time period for providing the documents
    (to be determined based on the circumstances).

19
20
Exemptions
  • There may be cases of certain donated consumer
    products where requirements to prepare and
    maintain documents would do little to support
    product traceability.
  • e.g. When a donation is from a person other than
    a manufacturer, importer, distributor, or
    retailer.
  • Health Canada is considering a regulatory
    proposal to allow for an exemption from the
    documentation related requirements in subsection
    13(1) to apply to persons when they are the
    recipients of certain donations of consumer
    products.
  • Preliminary consultations for the making of
    Exemption Regulations concluded in the fall of
    2010. The department will proceed through the
    established consultative process.

20
20
21
Exemptions
  • Proposed Exemption Regulations would also allow,
    under very specific conditions, the manufacture,
    importation, advertisement or sale of
    non-compliant consumer products solely for the
    purposes of
  • export
  • bringing the products into compliance
  • or for testing, research or exhibition.

21
22
Tests, Studies and other Information
  • The Minister of Health may order manufacturers
    and importers to conduct tests or studies and
    compile other information necessary to verify
    compliance or prevent non-compliance with the
    CCPSA or its regulations.

22
23
Confidential Business Information Personal
Information
  • Personal Information
  • Disclosure to a person or government carrying out
    functions relating to the protection of human
    health or safety without consent where it is
    necessary to identify or address a serious danger
    to human health or safety.
  • Does not affect provisions of the Privacy Act.
  • Confidential Business Information
  • The CCPSA outlines two circumstances in which may
    disclose without consent
  • Disclosure to a person or government that carries
    out functions relating to the protection of human
    health or safety or the environment if have
  • agreement in writing to maintain confidentiality
    of the information and use it only for the
    protection of human health or safety or the
    environment
  • Disclosure if essential to address a serious and
    imminent danger to human health or safety or the
    environment and essential to address the danger
    person to whom the information relates must be
    notified
  • does not affect provisions of the Access to
    Information Act.

23
24
Compliance and Enforcement
  • Offences (s.41-48)
  • Increased fines and penalties, including higher
    penalties where it can be proved that the
    contravention was done knowingly or recklessly.
  • Administrative Monetary Penalties (AMPS)
    (s.49-66)
  • Contravention of an order made under s. 31 or 32
    may lead to issuance of a Notice of Violation
    (NoV)
  • An NoV would state the monetary penalty to be
    paid by the company amount of penalty depends on
    the risk associated with the product (low,
    medium, high) and the companys history of
    violations (0, 1, gt1).
  • Majority of the authorities and requirements are
    in the CCPSA, but some requirements need to be
    implemented through regulations.
  • Regulations for Administrative Monetary Penalties
    (Canada Gazette process) (early consultation
    completed November 26, 2010).

24
25
National Outreach Campaign
  • Health Canadas Consumer Product Safety
    Directorate has initiated a national outreach
    campaign to promote the new legislation which
    includes activities such as public notice ads,
    information sessions, printed materials, videos
    and webcasts.
  • These initiatives will support industry and
    consumer awareness of requirements under the
    Canada Consumer Product Safety Act which came
    into force on June 20, 2011.
  • After June 20, 2011, there will be continued
    outreach as we continue to maintain and further
    develop relationships with industry and other
    stakeholders throughout Canada.
  • In addition to information sessions there will be
    webinars presented in the coming weeks.

25
25
26
Industry Engagement
Health Canada has been providing industry
information sessions on the implementation of the
CCPSA across Canada. HC will also be posting
recordings in both official languages of the
information session and provide interactive
webinars.
26
27
Partnerships with Stakeholders
  • Build partnerships with key stakeholders to
    diffuse information to help industry understand
    and comply with the new legislation.
  • Pursue outreach initiatives on multiple levels
  • Information and training sessions across Canada
  • Guidance documents, Fact Sheets and Reference
    Guides
  • Webcasts of Information Sessions posted on HC web
    site to inform those who cannot attend in person
  • Videos posted on HC web site, YouTube and on
    various stakeholders sites
  • Consumer Product Safety web site links posted on
    various stakeholders sites
  • Material for stakeholders web sites and their
    e-newsletters
  • International initiatives for exporters to
    Canada.

27
27
Write a Comment
User Comments (0)
About PowerShow.com